Stockreport

scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body Infusor

scPharmaceuticals Inc.  (SCPH) 
Last scpharmaceuticals inc. earnings: 3/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: scpharmaceuticals.com
PDF Advancing FUROSCIX® with the SmartDose® Drug Delivery System Forecast 2018 year-end cash of $82 - $87 million and 2019 expenditures of $8 - $10 million per quarter BUR [Read more]